COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies

Detalles Bibliográficos
Autores principales: Eyal, Nir, Caplan, Arthur, Plotkin, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Coronavirus – Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920165/
https://www.ncbi.nlm.nih.gov/pubmed/33905309
http://dx.doi.org/10.1080/21645515.2021.1917240
_version_ 1784669068076253184
author Eyal, Nir
Caplan, Arthur
Plotkin, Stanley
author_facet Eyal, Nir
Caplan, Arthur
Plotkin, Stanley
author_sort Eyal, Nir
collection PubMed
description
format Online
Article
Text
id pubmed-8920165
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-89201652022-03-15 COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies Eyal, Nir Caplan, Arthur Plotkin, Stanley Hum Vaccin Immunother Coronavirus – Letters Taylor & Francis 2021-04-27 /pmc/articles/PMC8920165/ /pubmed/33905309 http://dx.doi.org/10.1080/21645515.2021.1917240 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Coronavirus – Letters
Eyal, Nir
Caplan, Arthur
Plotkin, Stanley
COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies
title COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies
title_full COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies
title_fullStr COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies
title_full_unstemmed COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies
title_short COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies
title_sort covid vaccine efficacy against the b.1.351 (“south african”) variant—the urgent need to lay the groundwork for possible future challenge studies
topic Coronavirus – Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920165/
https://www.ncbi.nlm.nih.gov/pubmed/33905309
http://dx.doi.org/10.1080/21645515.2021.1917240
work_keys_str_mv AT eyalnir covidvaccineefficacyagainsttheb1351southafricanvarianttheurgentneedtolaythegroundworkforpossiblefuturechallengestudies
AT caplanarthur covidvaccineefficacyagainsttheb1351southafricanvarianttheurgentneedtolaythegroundworkforpossiblefuturechallengestudies
AT plotkinstanley covidvaccineefficacyagainsttheb1351southafricanvarianttheurgentneedtolaythegroundworkforpossiblefuturechallengestudies

Ejemplares similares